Welcome to our dedicated page for RYMDF news (Ticker: RYMDF), a resource for investors and traders seeking the latest updates and insights on RYMDF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RYMDF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RYMDF's position in the market.
Relay Medical Corp and Fio Corporation, through their joint venture Fionet Rapid Response Group Inc, have launched a multi-million-dollar COVID-19 rapid testing program at Toronto Pearson Airport, funded by the Canadian government. The Fionet Platform will manage testing for airport employees and travelers, enabling rapid results within 20 minutes. This initiative responds to new U.S. testing mandates for international arrivals. The partnership aims to meet increasing demands for mass testing solutions, particularly amid rising COVID-19 variant concerns.
Relay Medical Corp. has entered a Share Exchange Agreement to acquire Cybeats Technologies for $7,180,000, with a combination of cash and shares. This acquisition aims to enhance Relay's cybersecurity capabilities for IoT devices, crucial given the projected $73 billion market for IoT security by 2026. Cybeats' platform secures connected devices against cyber threats, offering real-time protection and monitoring. The deal includes milestone shares contingent upon Cybeats meeting revenue goals within 18 to 42 months post-acquisition.
Relay Medical Corp. (RYMDF) and Fio Corporation have partnered to produce high-volume COVID-19 mobile testing devices with KeyTronic, a renowned FDA-approved contract manufacturer. The assembly line for these devices is expected to start in October, with an initial run of 165 units. Meanwhile, Fionet has been deployed in 10 clinics in Kenya, and FRR is pursuing regulatory approval from Health Canada, the US, and the EU. This initiative aims to facilitate community-based testing amid the anticipated second wave of COVID-19.